Corient Private Wealth’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Sell
16,864
-3,075
-15% -$72.5K ﹤0.01% 2461
2026
Q1
$446K Buy
19,939
+12,167
+157% +$288K ﹤0.01% 2094
2025
Q4
$207K Sell
7,772
-840
-10% -$24.8K ﹤0.01% 2406
2025
Q3
$261K Sell
8,612
-1,614
-16% -$48.9K ﹤0.01% 2202
2025
Q2
$321K Buy
10,226
+2,599
+34% +$86K ﹤0.01% 1953
2025
Q1
$291K Buy
+7,627
New +$324K ﹤0.01% 1870

Other funds holding ENOV

Corient Private Wealth's ENOV Position: Q2 2026 in Review

Corient Private Wealth reduced its Enovis (ENOV) stake by 15% in Q2 2026, selling an estimated $72.5K and leaving 16,864 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Corient Private Wealth first reported a position in ENOV in Q1 2025 and has held it in 6 quarters since. The position peaked at $446K in Q1 2026. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Corient Private Wealth held 16,864 shares of Enovis worth $349K as of Q2 2026.
  • Corient Private Wealth sold 3,075 Enovis shares in Q2 2026, an estimated $72.5K.
  • Enovis made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2461 holding.
  • Corient Private Wealth first reported a position in Enovis in Q1 2025 and has held it in 6 quarters since.
  • Corient Private Wealth's Enovis position peaked at $446K in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.